Janux Therapeutics (JANX) Change in Receivables (2020 - 2026)
Janux Therapeutics' (JANX) quarterly Change in Receivables came in at $35.0 million in Q1 2026, up 401.36% on a QoQ basis from $7.0 million in Q2 2024.
Janux Therapeutics (JANX) Change in Receivables (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of Change in Receivables data on file, last reported at $35.0 million in Q1 2026.
- On a quarterly basis, Change in Receivables changed N/A year-over-year to $35.0 million in Q1 2026; TTM through Mar 2026 was $42.0 million, a 459.75% increase from a year earlier, with the FY2021 full-year figure at -$8.0 million, down 200.0% from the prior year.
- Change in Receivables for Q1 2026 stood at $35.0 million, up from $7.0 million in the prior quarter.
- Over the last five years, Change in Receivables for JANX reached as high as $35.0 million in Q1 2026 and fell as low as -$750000.0 in Q2 2023.
- Historically, Change in Receivables has averaged $6.1 million across 4 years, with a median of $519000.0 in 2024.
- On a YoY basis, Change in Receivables climbed as much as 1030.8% in 2024 and fell as far as 30.8% in 2024.
- Year by year, Change in Receivables stood at -$500000.0 in 2022, then slumped by 50.0% to -$750000.0 in 2023, then surged by 1030.8% to $7.0 million in 2024, then soared by 401.36% to $35.0 million in 2026.
- Per Business Quant data, the three most recent Change in Receivables figures were $35.0 million in Q1 2026, $7.0 million in Q2 2024, and $519000.0 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 75.30 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -39.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -1.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Janux Therapeutics | 964.43 Mn | 964.43 Mn | - | 35.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.00 Mn |
| Mar 31, 2026 | 35.00 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Jun 30, 2024 | 6.98 Mn |
| Mar 31, 2024 | 519,000.00 |
| Mar 31, 2024 | 519,000.00 |
| Jun 30, 2023 | -750,000.00 |
| Jun 30, 2023 | -750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Mar 31, 2023 | 750,000.00 |
| Dec 31, 2022 | -500,000.00 |
| Dec 31, 2022 | -500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Sep 30, 2021 | -375,000.00 |
| Sep 30, 2021 | -375,000.00 |
| Mar 31, 2021 | -7.63 Mn |
| Mar 31, 2021 | -7.63 Mn |
| Dec 31, 2020 | 8.00 Mn |
| Dec 31, 2020 | 8.00 Mn |